In a second #OnRarePodcast with Eric, who lives with transthyretin amyloid cardiomyopathy (ATTR-CM), he discusses how transthyretin can build up all over the body, specifically in the heart, which led to him needing a heart transplant. Listen into Eric’s story to learn more: https://bit.ly/3WqcnJG
BridgeBio’s Post
More Relevant Posts
-
Hypertrophic Cardiomyopathy ( HCM) is the most common cardiac disease in cats. This video is helpful on how to diagnose hypertrophy by echocardiography.
Check out the full video, “How to Measure Wall Thickness with Echocardiography,” from our Microlesson Series on Hypertrophic Cardiomyopathy (#HCM)! Watch it here: bit.ly/3LydPTe
To view or add a comment, sign in
-
Check out the full video, “How to Measure Wall Thickness with Echocardiography,” from our Microlesson Series on Hypertrophic Cardiomyopathy (#HCM)! Watch it here: bit.ly/3LydPTe
To view or add a comment, sign in
-
If you're a visual learner, this HCM Microlesson Series from ASE is for you! 👀 These videos are great teaching and reference tools for both new and more seasoned sonographers to help avoid common pitfalls when scanning and measuring for HCM, as well as help with identification and quantification! It's important we keep brushed up on this and other pathologies, even if we don't see them often in our own practice.
Check out the full video, “How to Measure Wall Thickness with Echocardiography,” from our Microlesson Series on Hypertrophic Cardiomyopathy (#HCM)! Watch it here: bit.ly/3LydPTe
To view or add a comment, sign in
-
https://lnkd.in/gnf3mFy3 Article title: What is the best way to measure blood pressure? Author(s): Fernando Nobre*; Décio Mion Júnior Journal: Annals of Circulation Journal ISSN: 2641-2985 Main article text: Since Scipiano Riva-Rocci [1] created the device to measure Blood Pressure (BP), more than a century has passed with gains in knowledge of this way of assessing BP. #AcuteCoronarySyndrome #AnginaPectoris #AorticDissection #AtrialFibrillation #Peertechz #PeertechzPublications #Cardiomyopathy #CardiovascularDiseases #CongenitalHeartDisease #CoronaryArteryDisease #Endocarditis #PercutaneousCoronaryIntervention #PulmonaryEmbolism
To view or add a comment, sign in
-
-
📉 A study led presented at #AHA24, analyzes the #cost #burden of #transthyretin #amyloid #cardiomyopathy vs #nonamyloid #heartfailure. 🥼 Dr. Amit Goyal of the CardioNerds discusses the findings here:
To view or add a comment, sign in
-
https://lnkd.in/g-vDNBfX Article title: Evaluating the relevance and clarity of the heart failure eMeasure implementation toolkit by using a web-based survey instrument Author(s): Megha Kalsy; Katherine Sward; Bruce Bray; Andrew Redd; Karen Eilbeck; Jennifer H Garvin Journal: Annals of Circulation Journal ISSN: 2641-2985 Abstract: The impact on workflow is an important component in determining whether an HIT implementation will be successful. Workflow is, unfortunately, a concept that is often ignored when implementing HIT and the literature about workflow in domains of quality improvement, system implementation, and process improvement has not been adequate. HIT is not always designed to fit the workflow of a given organization, making it difficult to truly assess HIT impact on outcomes or processes. #eMeasures #QualityImprovement #HealthInformatics #Survey #HeartFailure #ImplementationToolkit #AcuteCoronarySyndrome #AnginaPectoris #AorticDissection #AtrialFibrillation #Peertechz #PeertechzPublications #Cardiomyopathy #CardiovascularDiseases #CongenitalHeartDisease #CoronaryArteryDisease #Endocarditis #PercutaneousCoronaryIntervention #PulmonaryEmbolism
To view or add a comment, sign in
-
-
An important landmark in the treatment of hypertrophic cardiomyopathy.
Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study. #HeartFailure2024 #HFA_ESC
To view or add a comment, sign in
-
-
Have you read our State-of-the-Art Review, "Obstruction in Hypertrophic Cardiomyopathy: Many Faces?" Read the JASE article here: bit.ly/3KqJxl1
To view or add a comment, sign in
-
-
Hot on the heels of mavacamten, another myosin inhibitor, aficamten, shines in restoring cardiorespiratory function in obstructive hypertrophic cardiomyopathy. 🫀 And what better way to prove this than via a cardiopulmonary exercise test (CPET) to demonstrate an objective improvement in peak VO2. 🏃♂️ Exciting times in cardiology with an ever expanding array of medications to help our patients without resorting to surgery as first line therapy. ☺️ #hocm #myosininhibitor
Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study. #HeartFailure2024 #HFA_ESC
To view or add a comment, sign in
-
-
A hugely important study on structural inequalities in provision and outcomes of therapeutuc hypothermia for HIE. Similar inequalities have been reported more generally across UK maternity care and it would be great to see more data shining a light on this important issue for mothers and newborns. Aduragbemi Banke-Thomas
🔎 Explore our latest visual abstract, part of our monthly curated publications list! 👶🧠 Racial and Ethnic Inequities in Therapeutic Hypothermia and Neonatal Hypoxic-Ischemic Encephalopathy: A Retrospective Cohort Study Check out the full list of highlighted articles from June and recent months! 👉 http://bit.ly/45el9fM #newbornbrains #HIE
To view or add a comment, sign in
-